FDA — authorised 22 March 1994
- Application: NDA020237
- Marketing authorisation holder: ADVANZ PHARMA
- Status: supplemented
FDA authorised Salagen on 22 March 1994
Yes. FDA authorised it on 22 March 1994; FDA has authorised it.
ADVANZ PHARMA holds the US marketing authorisation.